world-biomarkers-pharma-biotech-2017-posters

42 / 61

Volume10, Issue 12 (Suppl) J Proteomics Bioinform, an open access journal
ISSN: 0974-276X
Page 99
conferenceseries.com
World Biomarkers & Pharma Biotech 2017
December 07-09, 2017
December 07-09, 2017 | Madrid, Spain
&
20th International Conference on
PHARMACEUTICAL BIOTECHNOLOGY
9th WORLD BIOMARKERS CONGRESS
JOINT EVENT ON
Biotechnology and people’s health: The infectious diseases and phytonutraceuticals factor
Abayomi Oguntunde1, Victor O Fadipe1,2, Fashina Sanya1 and Ibrahim H Doko5
1Federal Ministry of Science and Technology, Nigeria
2University of Zululand, South Africa
3Raw Materials Research and Development Council, Nigeria
Phytonutraceuticals generally promises to have greater impacts on health delivery and its management ranging from drug
discovery and disease diagnosis. Phytonutraceuticals in both developed and developing countries are alive with rare species
that possess pharmacologically active constituents for possible cure of many chronic diseases such as cancer, Tuberculosis, HIV/
AIDs, sickle cell anaemia, neurological disorders, and many metabolic diseases. Phytonutraceuticals is a mixture of compounds
such as carotenoids, flavonoids and Isoflavonoids (Polyphenols), Phytates (Inositol phosphates), Lignans, Isothiocynates and
Indoles, Phenols, Sulphides and Thiols, Terpenes and thus serves as antioxidants, enhance immune response, enhance cell-cell
communication, alter estogen metabolism, repair DNA damage caused by smoking and other toxin exposures, others. The
Phytonutraceuticals revolution began in the 1980s as a result of substantial evidence to support increase in life expectancy after
its administration directly or as foods. The high cost of orthodox medicine pave way for the emergency of Phytonutraceuticals
in countries like US, EU and JAPAN. Most African countries rural dwellers depend on Phytonutraceuticals. Literature have
it that, most of these plants from savannah and tropical rainforest bio accumulates such Phytonutraceuticals in minute’s
quantities that are not enough to characterise it and biotechnology is right now the rapidly advancing frontier of science. It
has illuminated more deeply and more extensively many genetic, chemical, physiological, and mathematical processes which
can be used to mass produce biologically active Phytonutraceuticals in plants. The main objective of the study is to bring to
fore the advance in evolution of biotechnology techniques as it affects Phytonutraceuticals development. This will further
strengthen research collaboration involving botanist, biotechnologist and chemist etc to further strengthening better health
care management.
J Proteomics Bioinform 2017, 10:12(Suppl)
DOI: 10.4172/0974-276X-C1-110